Although the finding of higher pre-treatment IL-1β, IL-12, and TNF-α levels in survivors suggests they serve as protective biomarkers in individuals with kala-azar, the accuracy was not sufficient for adequate diagnostic utility. Here, IL1B is linked to visceral leishmaniasis.